EUVIMEDEUVIMED entdecken
Leitlinie

Analytical Method Development and Validation of Oxaceprol by RP-HPLC According to ICH Guidelines

Divya Shivanath Deshmukh, Sachin Mahadu Bhalekar, Apeksha Dalavi, Rutuja Sunil Chavan, Lokhande Rahul Prakash, Ganesh Jayram Lamkhade, Omkar Rajaram Gosavi, Ramteke Kuldeep

International Journal of Drug Delivery Technology · 19.06.2026 · 16 (56s)

DOI: 10.25258/ijddt.16.56s.83 ↗

Kurz gefasst

Leitlinie in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 19.06.2026. Verfasst von Divya Shivanath Deshmukh und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chromatographic separation was achieved on an Agilent Zorbax C18 column (250 x 4.6 mm, 5 µm particle size) using an isocratic mobile phase of potassium dihydrogen orthophosphate buffer (pH 3.0 ± 0.05) and acetonitrile in the ratio 70:30 (v/v), delivered at 1.0 mL/min. UV detection was at 211 nm (injection volume: 20 µL). Oxaceprol eluted as a sharp, symmetrical peak at a retention time of 5.928-5.933 minutes. The method was fully validated per ICH Q2 (R2) (2023) for: specificity, system precision, method precision, intermediate precision (inter-day), accuracy (spike-recovery), linearity and range, and solution stability. The calibration curve demonstrated excellent linearity (r = 0.9997; R² = 0.9993) over 160-240 µg/mL (80-120% of nominal). System precision %RSD was 0.38% (Day 1) and 0.78% (Day 2), both well below the 2.0% acceptance criterion. Mean accuracy recovery was 100.35% ± 0.25% RSD at 80%, 100%, and 120% concentration levels. Solution stability was confirmed for 24 hours at ambient temperature (maximum difference from initial: 0.72%). The method is recommended for routine QC and stability testing of Oxaceprol 200 mg tablets and is suitable for submission to Scopus-indexed pharmaceutical journals.

Zitieren

APA

Deshmukh, D. S., Bhalekar, S. M., Dalavi, A., Chavan, R. S., Prakash, L. R., Lamkhade, G. J., Gosavi, O. R., & Kuldeep, R. (2026). Analytical Method Development and Validation of Oxaceprol by RP-HPLC According to ICH Guidelines. International Journal of Drug Delivery Technology, 16(56s). https://doi.org/10.25258/ijddt.16.56s.83

Vancouver

Deshmukh DS, Bhalekar SM, Dalavi A, Chavan RS, Prakash LR, Lamkhade GJ, et al. Analytical Method Development and Validation of Oxaceprol by RP-HPLC According to ICH Guidelines. International Journal of Drug Delivery Technology. 2026;16(56s). doi:10.25258/ijddt.16.56s.83

BibTeX
@article{Deshmukh2026,
  author = {Deshmukh, Divya Shivanath and Bhalekar, Sachin Mahadu and Dalavi, Apeksha and Chavan, Rutuja Sunil and Prakash, Lokhande Rahul and Lamkhade, Ganesh Jayram and Gosavi, Omkar Rajaram and Kuldeep, Ramteke},
  title = {Analytical Method Development and Validation of Oxaceprol by RP-HPLC According to ICH Guidelines},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {56s},
  doi = {10.25258/ijddt.16.56s.83}
}
Kostenlos starten →